Product Information
VERAPAMIL SR 360 MG CAPSULE is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $7.8839 per EA under NDC 00591288601. Its NADAC has been published 667 times since Nov 28, 2013.
FDA first approved this application on May 29, 1990. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
360 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00591288601
Classification
Generic
Dosage Form
CAPSULE, DELAYED RELEASE PELLETS
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
VERAPAMIL HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA019614FDA Approved
5/29/1990
TE Code
AB
On Market Since
5/29/1990
Pharmacological Classes
Price Statistics
The NADAC for VERAPAMIL SR 360 MG CAPSULE has been published 667 times since Nov 28, 2013, and over the history we have for it it has risen 455.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $7.8839 per EA |
|---|---|
| All-time high | $8.4534 (May 13, 2026) |
| All-time low | $1.3912 (Jan 21, 2015) |
| 52-week high | $8.4534 |
| 52-week low | $5.5522 |
| Median price | $4.2792 |
| Average price | $4.0963 |
| Largest weekly change | +84.6% (May 20, 2015) |
| Weeks tracked | 667 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
-2.1%
6M
-5.7%
1Y
+42.0%
3Y
+72.4%
5Y
+70.9%
All
+455.6%
Last surveyed Sep 2, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 1% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Teva Pharmaceuticals USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
verapamil hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Calcium Channel Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of VERAPAMIL SR 360 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for VERAPAMIL SR 360 MG CAPSULE, manufactured by Teva Pharmaceuticals USA Inc., is $7.8839 per EA (NDC 00591288601), effective Sep 2, 2026.
How has the price of VERAPAMIL SR 360 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for VERAPAMIL SR 360 MG CAPSULE has risen 455.6%. It has been tracked across 667 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for VERAPAMIL SR 360 MG CAPSULE?
Since Nov 28, 2013, the NADAC for VERAPAMIL SR 360 MG CAPSULE has ranged from a low of $1.3912 (Jan 21, 2015) to a high of $8.4534 (May 13, 2026), with a median of $4.2792 per EA.
Are there cheaper alternatives to VERAPAMIL SR 360 MG CAPSULE?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, VERAPAMIL SR 360 MG CAPSULE, is $7.8024 per EA — about 1% below VERAPAMIL SR 360 MG CAPSULE.
Who manufactures VERAPAMIL SR 360 MG CAPSULE?
VERAPAMIL SR 360 MG CAPSULE (NDC 00591288601) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.